AXA China Region Insurance Company (Bermuda) Limited, together with AXA International Reinsurance (Shanghai) Company Limited ( AXA), has signed a strategic Memorandum of Understanding (MoU) with China Biotech Services Holdings Limited. The collaboration aims to explore innovative cancer treatment technologies, including Boron Neutron Capture Therapy (BNCT) and related services, with the goal of providing customers with a broader range of treatment options.